DJIA 17,416.85 225.48 1.31%
NASDAQ 4,683.41 45.41 0.98%
S&P 500 2,021.25 19.09 0.95%
market minute promo

74.86 0.22 (0.29%)

Quote as of

Extended Hours: $74.02 -$0.84 (-1.12%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

GWPH $74.86 0.29%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $74.55
Previous Close $74.64
Daily Range $72.01 - $74.98
52-Week Range $41.86 - $111.46
Market Cap $1.5B
P/E Ratio -124.40
Dividend (Yield) $0.00 (0.0%)
Volume 171,052
Average Daily Volume 385,815
Current FY EPS -$4.65

Sector

Industry

GW Pharmaceuticals Plc (ADR) (GWPH) Description

GW Pharmaceuticals Plc - American Depositary Shares Website: http://www.gwpharm.com/

News & Commentary

In Case You Missed It, This New Marijuana Study Has a Smoking Revelation

Studies on marijuana's long-term health effects are few and far between, which is why this recently released study is bound to raise a few eyebrows.

12 Marijuana Stocks For Your Do Not 'Buy And Hold' List - Part VIII

Inter Parfums (IPAR) Robust Sales Growth, GW Pharmaceuticals (GWPH) Upcoming Moment Of Truth

No More Needle Pricks? Potentially Game-Changing News for People With Diabetes

Finger pricks are a common method used by diabetics to check their blood sugar levels. But what if that was about to be a thing of the past?

12 Marijuana Stocks For Your Do Not 'Buy And Hold' List - Part VII

The Marijuana Market Is Expanding: Here Are A Couple Ways To Get Involved

Marijuana Stocks 2015: What You Need to Know

Marijuana use and legalization has gotten a lot of buzz lately, but what does it mean for investors?

This Is Where The Investment Opportunity Is Right Now In Cannabis

Is 1 Drug Really Outselling Legalized Marijuana?

Legalized marijuana is reportedly the fastest growing industry in the U.S. right now. Even so, this single drug vastly outsells the entire industry -- and probably will for years to come.

Could This Recent Study on Casual Marijuana Use Crush Marijuana's Momentum?

A recently released marijuana study expounds on the idea that casual marijuana users may be susceptible to long-term adverse effects from the drug. Does this data doom the medical marijuana industry?

See More GWPH News...